We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
1601
DELISTED
CyberArk
CYBR
| $803K | ﹤0.01% |
+19,400
| New | +$849K |
|
1602
ICICI Bank
IBN
$106B
| $800K | ﹤0.01% |
82,210
+71,760
| +687% | +$661K |
|
1603
Orion Group Holdings
ORN
$514M
| $798K | ﹤0.01% |
101,967
-9,900
| -9% | -$73.5K |
|
1604
Tootsie Roll Industries
TR
$2.82B
| $798K | ﹤0.01% |
28,618
+3,230
| +13% | +$90.4K |
|
1605
Addus HomeCare
ADUS
$2.14B
| $797K | ﹤0.01% |
22,900
-7,500
| -25% | -$255K |
|
|
PGRE
1606
DELISTED
Paramount Group
PGRE
| $794K | ﹤0.01% |
+50,076
| New | +$803K |
|
|
SGY
1607
DELISTED
Stone Energy
SGY
| $794K | ﹤0.01% |
24,700
+11,900
| +93% | +$346K |
|
1608
Employers Holdings
EIG
$908M
| $789K | ﹤0.01% |
17,780
-5,400
| -23% | -$255K |
|
|
GLDD
1609
DELISTED
Great Lakes Dredge & Dock
GLDD
| $782K | ﹤0.01% |
144,767
+4,800
| +3% | +$24.4K |
|
1610
Westwood Holdings Group
WHG
$182M
| $781K | ﹤0.01% |
11,800
-100
| -0.8% | -$6.64K |
|
|
VG
1611
DELISTED
Vonage Holdings Corporation
VG
| $781K | ﹤0.01% |
+76,760
| New | +$701K |
|
|
ASNA
1612
DELISTED
Ascena Retail Group, Inc.
ASNA
| $778K | ﹤0.01% |
16,554
+4,215
| +34% | +$178K |
|
1613
Banco Santander
SAN
$194B
| $774K | ﹤0.01% |
123,431
+6,666
| +6% | +$42.1K |
|
1614
Travere Therapeutics
TVTX
$5.33B
| $773K | ﹤0.01% |
36,700
-34,300
| -48% | -$784K |
|
|
CHFN
1615
DELISTED
Charter Financial Corp
CHFN
| $768K | ﹤0.01% |
43,779
-5,100
| -10% | -$93.9K |
|
|
GCAP
1616
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $767K | ﹤0.01% |
76,749
-10,000
| -12% | -$71.7K |
|
1617
RTX Corp
RTX
$287B
| $766K | ﹤0.01% |
9,545
-197,831
| -95% | -$15M |
|
|
COBZ
1618
DELISTED
CoBiz Financial,Inc
COBZ
| $764K | ﹤0.01% |
38,237
-1,900
| -5% | -$38.5K |
|
1619
National Healthcare
NHC
$3.53B
| $761K | ﹤0.01% |
12,491
+800
| +7% | +$51K |
|
1620
FormFactor
FORM
$8.11B
| $759K | ﹤0.01% |
48,529
+11,692
| +32% | +$196K |
|
|
CHMI
1621
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $757K | ﹤0.01% |
42,100
+8,000
| +23% | +$147K |
|
|
SRDX
1622
DELISTED
Surmodics
SRDX
| $757K | ﹤0.01% |
27,039
-5,600
| -17% | -$171K |
|
|
COTV
1623
DELISTED
Cotiviti Holdings, Inc.
COTV
| $757K | ﹤0.01% |
23,500
+7,800
| +50% | +$259K |
|
|
OSG
1624
DELISTED
Overseas Shipholding Group Inc.
OSG
| $756K | ﹤0.01% |
275,954
+62,838
| +29% | +$163K |
|
1625
Great Southern Bancorp
GSBC
$863M
| $753K | ﹤0.01% |
14,580
+2,900
| +25% | +$156K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.